The following articles are based on information gathered from numerous sources. The information contained in these articles are not substantiated and may be based on opinions. They are only for reference, and in no way are to be relied upon as factual.

No guarantee whatsoever is made that any of the articles contained herein are accurate. There is absolutely no assurance that any statement contained in, or cited in an article is true, correct, precise, or up-to-date. The majority of such articles are written, in part or in whole, by nonprofessionals.

The information provided is, at best, of a general nature and cannot substitute for the advice of qualified researchers or professionals. None of the individual contributors, or anyone else connected to www.extremepeptides.com take any responsibility whatsoever for the results or consequences of any attempt to use, or adopt any of the information presented in these articles as factual or substantiated.

Qualities of GHRP6 – Additional GHRP Releasers

(Click here to read our disclaimer)

There are a variety of GHRP chemicals, both in natural and artificial settings.

These hormones are designed to time the growth and creation of additional tissue. In scientific study these hormones are used to determine their effects of various chemicals.

Additional GHRP Releasers

The GHRP series is a group of hexapeptides that is designed to mimic natural growth releasers.

  • Basic versions of these peptides include GHRP1, GHRP2 and GHRP6. These are available in natural forms, though the artificial versions of these chemicals have slightly different properties and are not considered for bodily use.
  • GHRP6 has been used as a template to help create additional peptides that have tetra penta and pseudotripepide properties.
  • These have a very different structural homology and have different receptors that do not respond to the pituitary and hypothalamic glands the way the natural substances would.

GHRP chemicalsMuch of the work that has been done to study these receptors has been done by cloning the original hormone, both to provide researchers with plenty of the chemical for rounds of experiments and to determine the best method for producing an artificial version of the hormone for potential use.

However, these cloned versions do not have the same homology as the natural receptors.


Studying the variance of GHRP variants suggests the natural versions of these chemicals contain a ligand that has not yet been discovered.

  • The GHRP series likely have two sites of action that will allow it to interact with both the hypothalamus and the pituitary gland as necessary. This is likely to help some hormones regulate somatostatin or other factors that help to address hypothalamic factures.
  • Any chemical versions of these hormones cannot include any opioid receptor antagonists that would allow them to interact with male or female organisms in an alternate manner.
  • The opioid receptor antagonists that appear in certain types of natural some hormones can neutralize the effects or influences of chemicals like GHRP6. In a natural state this is designed to ensure regulation of hormones in a system, but in an artificial state this can negatively impact the ability to study the effects of these chemicals.

Studies of GHRP6 and its impact on free fatty acids, neurotransmitters, rhGH, glucocorticoids or exogenous somaostatin are ongoing to better understand the chemical design of manufactured GHRP6.

Ongoing insight on the GHRP chemical base can allow scientists to make more precise versions of these chemicals for further study.

Click here to view the homepage of our store.

Click here to view our entire PDF research library

Click here to view or download this article in PDF format

CJC 1295 – Precise Methodology

(Click here to read our disclaimer)

The natural occurring base of CJC 1295 was discovered in different parts of plants species in 1995 including leaves, stems and seeds. The original purpose of this biological CJC 1295 production is still unknown but there are suggestions that it protected plants during evolution against harsh environments. Researchers have been able to link this chemical to regulation of diminished root growth and higher above ground growth.

High Concentration of GHRH

In 2001, at the Department of Cellular and Structural Biology at the University of Texas, researchers discovered high concentrations of GHRH in two species of wild cherries.This was one of the early observational research projects to determine what effect GHRH played in plant growth at a cellular level.

The report suggested that the high levels were part of the photoperiodism that dictated and directed plant growth and bearing of fruit. These high levels were not observed during non-fruit bearing periods.

Biologists are especially excited about the potential of this discovery. These scientists hope that further and targeted research may lead to a method of controlling plant and vegetation growth that will enable increased ability to feed more people worldwide. The levels of GHRH vary widely from species to species as well as from each part of the same plant. Levels can be as small as pictograms to as large as micrograms within any given organism.

Precise Methodology

If scientists are able to distinguish the precise methodology used by various plants to increase production during particular periods and the environmental triggers can be replicated, there is potential that farmers will be able to produce greater quantities of food in smaller spaces. In addition, there is the possibility that vegetables and fruits may be able to be grown out of their normal season, making a substantially larger selection of food products available to the public.

In addition to identifying GHRH in plants, it has also been detected in bacteria and fungi. Few studies have begun and none yet concluded on the manner in which GHRH works in unicell and dinoflagellates. However, two observations of dinoflagellate Lingulodinium displayed affects that increased expanded lifecycles and reduced environmental stress on the invertebrates.

Implications of the Findings

This finding has implications in ecophysiology and in pharmacological advancement. In vertebrate and plant organisms, the action of GHRH appears to be incorporated in the circadian rhythms whereas in unicell and dinoflagellates there is no detection of this synthesis.

CJC 1295 with DAC is time released in a continuous stream instead of in short bursts as its counterpart, CJC 1295 NO DAC does. DAC stands for drug affinity complex, which is designed to increase the half-live effects of GHRH. Research on the effects of CJC 1295 with DAC is in the beginning stages and what few studies include stage one reports are thus far inconclusive.

Click here to view the homepage of our store.

Click here to view our entire PDF research library

Click here to view or download this article in PDF format